ENTEROL

Main information

  • Trade name:
  • ENTEROL Capsule, hard 250MG
  • Dosage:
  • 250MG
  • Pharmaceutical form:
  • Capsule, hard
  • Administration route:
  • Oral use
  • Units in package:
  • 30 Blister
  • Prescription type:
  • OTC medicinal products
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENTEROL Capsule, hard 250MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • SACCHAROMYCES BOULARDII
  • Product summary:
  • ENTEROL

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 49/ 167/02-C
  • Last update:
  • 04-04-2018

28-9-2018

Peer review of the pesticide risk assessment of the active substance ABE‐IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623)

Peer review of the pesticide risk assessment of the active substance ABE‐IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623)

Published on: Thu, 27 Sep 2018 00:00:00 +0200 The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, France, for the pesticide active substance ABE‐IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623) are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the...

Europe - EFSA - European Food Safety Authority Publications

There are no news related to this product.